These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22335800)

  • 1. CpG-enriched plasmid enhances the efficacy of the traditional foot-and-mouth disease killed vaccine.
    Guo X; Jia H; Zhang Q; Yuan W; Zhu G; Xin T; Zhu H; Sánchez-Vizcaíno JM
    Microbiol Immunol; 2012 May; 56(5):332-7. PubMed ID: 22335800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
    Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
    Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
    Blignaut B; Visser N; Theron J; Rieder E; Maree FF
    J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18.
    Ma M; Jin N; Shen G; Zhu G; Liu HJ; Zheng M; Lu H; Huo X; Jin M; Yin G; Ma H; Li X; Ji Y; Jin K
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):1-7. PubMed ID: 17706296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
    Ren J; Yang L; Xu H; Zhang Y; Wan M; Liu G; Zhao L; Wang L; Yu Y
    Vaccine; 2011 Oct; 29(45):7960-5. PubMed ID: 21872635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to foot-and-mouth disease DNA vaccines can be enhanced by coinjection with the Isatis indigotica extract.
    Chen L; Lin T; Zhang H; Su Y
    Intervirology; 2005; 48(4):207-12. PubMed ID: 15920343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
    Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
    Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
    Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
    Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved immune responses and safety of foot-and-mouth disease vaccine containing immunostimulating components in pigs.
    Choi JH; You SH; Ko MK; Jo HE; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Lee JS; Park JH
    J Vet Sci; 2020 Sep; 21(5):e74. PubMed ID: 33016020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L; Moraes MP; Koster M; Burrage T; Pacheco JM; Segundo FD; Grubman MJ
    Vaccine; 2008 Oct; 26(45):5689-99. PubMed ID: 18762225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
    Brake DA; McIlhaney M; Miller T; Christianson K; Keene A; Lohnas G; Purcell C; Neilan J; Schutta C; Barrera J; Burrage T; Brough DE; Butman BT
    Dev Biol (Basel); 2012; 134():123-33. PubMed ID: 22888605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection.
    Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y
    Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mucosal vaccine against foot-and-mouth disease virus induces protection in mice and swine.
    Song H; Wang Z; Zheng D; Fang W; Li Y; Liu Y; Niu Z; Qiu B
    Biotechnol Lett; 2005 Nov; 27(21):1669-74. PubMed ID: 16247672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of plasmids encoding P12A and 3C of FMDV and swine IL-18.
    Mingxiao M; Ningyi J; Juan LH; Min Z; Guoshun S; Guangze Z; Huijun L; Xiaowei H; Minglan J; Xu L; Haili M; Yue J; Gefen Y; Kuoshi J
    Antiviral Res; 2007 Oct; 76(1):59-67. PubMed ID: 17606304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
    Fowler VL; Knowles NJ; Paton DJ; Barnett PV
    Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmid containing CpG motifs enhances the efficacy of porcine reproductive and respiratory syndrome live attenuated vaccine.
    Guo X; Zhang Q; Hou S; Zhai G; Zhu H; Sánchez-Vizcaíno JM
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):405-9. PubMed ID: 21917319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.
    Qian P; Li XM; Jin ML; Peng GQ; Chen HC
    Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs.
    Siva Reddy K; Muralidhar Rao D; Badrinaryana N; Suryanaryana VV; Reddy GR
    FEMS Immunol Med Microbiol; 2010 Dec; 60(3):261-9. PubMed ID: 21039923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
    Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
    Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.